Related Experiment Video
Updated: Dec 15, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Potential impact of SARS-CoV-2 infection on the thymus
Marvin Paulo Lins1,2, Salete Smaniotto1,2
1Laboratory of Cell Biology, Institute of Biological and Health Sciences, Federal University of Alagoas - Maceió/AL, Brazil.
Abstract:
Understanding the pathogenesis of certain viral agents is essential for developing new treatments and obtaining a clinical cure. With the onset of the new coronavirus (SARS-CoV-2) pandemic in the beginning of 2020, a rush to conduct studies and develop drugs has led to the publication of articles that seek to address knowledge gaps and contribute to the global scientific research community. There are still no reports on the infectivity or repercussions of SARS-CoV-2 infection on the central lymphoid organ, the thymus, nor on thymocytes or thymic epithelial cells. In this brief review, we present a hypothesis about lymphopenia observed in SARS patients and the probable pathological changes that the thymus may undergo due to this new virus.
Insights
The thymus, a key organ for immune cell development, may be impacted by SARS-CoV-2 infection. This review hypothesizes viral effects on the thymus and thymocytes, potentially explaining lymphopenia in COVID-19 patients.
Area of Science:
- Immunology
- Virology
- Pathogenesis
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, has spurred extensive research.
- Knowledge gaps persist regarding SARS-CoV-2's impact on the central lymphoid organ, the thymus.
Purpose of the Study:
- To hypothesize the effects of SARS-CoV-2 infection on the thymus and thymocytes.
- To explore the potential role of thymic pathology in SARS-CoV-2-induced lymphopenia.
Main Methods:
- This study is a brief review.
- It presents a hypothesis based on existing knowledge of viral pathogenesis and lymphopenia.
Main Results:
- No direct studies currently report SARS-CoV-2 infectivity or repercussions on the thymus.
- A hypothesis is proposed linking SARS-CoV-2 to thymic changes and lymphopenia.
Conclusions:
- The thymus and thymic epithelial cells may be targets of SARS-CoV-2.
- Thymic dysfunction could contribute to the observed lymphopenia in COVID-19 patients, necessitating further investigation.
More Related Videos
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

